Understanding Barriers to Glaucoma Treatment Adherence among Participants in South India

References

• Kingman S. Glaucoma is second leading cause of blindness globally. Bull World Health Organ. 2004;82(11):887–888.
   PubMed Web of Science ®Google Scholar
• Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262–267. doi:10.1136/bjo.2005.081224.
   PubMed Web of Science ®Google Scholar
• Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol. 2012;96(5):614–618. doi:10.1136/bjophthalmol-2011-300539.
   PubMed Web of Science ®Google Scholar
• Thulasiraj RD, Nirmalan PK, Ramakrishnan R, et al. Blindness and vision impairment in a rural south Indian population: the Aravind comprehensive eye survey. Ophthalmology. 2003;110(8):1491–1498. doi:10.1016/S0161-6420(03)00565-7.
   PubMed Web of Science ®Google Scholar
• George R, Arvind H, Baskaran M, Ramesh SV, Raju P, Vijaya L. The Chennai glaucoma study: prevalence and risk factors for glaucoma in cataract operated eyes in urban Chennai. Indian J Ophthalmol. 2010;58(3):243–245. doi:10.4103/0301-4738.62655.
   PubMed Web of Science ®Google Scholar
• Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121(11):2081–2090. doi:10.1016/j.ophtha.2014.05.013.
   PubMed Web of Science ®Google Scholar
• The Advanced Glaucoma Intervention Study (AGIS). The relationship between control of intraocular pressure and visual field deterioration.The AGIS investigators. Am J Ophthalmol. 2000;130(4):429–440. doi:10.1016/S0002-9394(00)00538-9.
   PubMed Web of Science ®Google Scholar
• Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E. Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol. 2003;121(1):48–56. doi:10.1001/archopht.121.1.48.
   PubMedGoogle Scholar
• Kass MA, Heuer DK, Higginbotham EJ, et al. The Ocular hypertension treatment study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002;120(6):701–713. discussion 829-730. doi:10.1001/archopht.120.6.701.
   PubMed Web of Science ®Google Scholar
• Malihi M, Moura Filho ER, Hodge DO, Sit AJ. Long-term trends in glaucoma-related blindness in Olmsted County, Minnesota. Ophthalmology. 2014;121(1):134–141. doi:10.1016/j.ophtha.2013.09.003.
   PubMed Web of Science ®Google Scholar
• Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120(10):1268–1279. doi:10.1001/archopht.120.10.1268.
   PubMed Web of Science ®Google Scholar
• Sleath B, Blalock S, Covert D, et al. The relationship between glaucoma medication adherence, eye drop technique, and visual field defect severity. Ophthalmology. 2011;118(12):2398–2402. doi:10.1016/j.ophtha.2011.05.013.
   PubMed Web of Science ®Google Scholar
• Rossi GC, Pasinetti GM, Scudeller L, Radaelli R, Bianchi PE. Do adherence rates and glaucomatous visual field progression correlate? Eur J Ophthalmol. 2011;21(4):410–414. doi:10.5301/EJO.2010.6112.
   PubMed Web of Science ®Google Scholar
• Olthoff CM, Schouten JS, van de Borne BW, Webers CA. Noncompliance with ocular hypotensive treatment in patients with glaucoma or ocular hypertension an evidence-based review. Ophthalmology. 2005;112(6):953–961. doi:10.1016/j.ophtha.2004.12.035.
   PubMed Web of Science ®Google Scholar
• Kass MA, Gordon M, Morley RE Jr., Meltzer DW, Goldberg JJ. Compliance with topical timolol treatment. Am J Ophthalmol. 1987;103(2):188–193. doi:10.1016/S0002-9394(14)74225-4.
   PubMed Web of Science ®Google Scholar
• Mehari T, Giorgis AT, Shibeshi W. Level of adherence to ocular hypotensive agents and its determinant factors among glaucoma patients in Menelik II Referral Hospital, Ethiopia. BMC Ophthalmol. 2016;16:131. doi:10.1186/s12886-016-0316-z.
   PubMed Web of Science ®Google Scholar
• Sleath BL, Krishnadas R, Cho M, et al. Patient-reported barriers to glaucoma medication access, use, and adherence in southern India. Indian J Ophthalmol. 2009;57(1):63–68. doi:10.4103/0301-4738.44495.
   PubMed Web of Science ®Google Scholar
• Thekkur P, Reddy MM, Ramaswamy G, Naik BN, Lakshminarayanan S, Saya GK. Medication adherence and its correlates among diabetic and hypertensive patients seeking care from primary health center, India. Int J Curr Res Rev. 2015;7(21):33.
   Google Scholar
• Arulmozhi S, Mahalakshmy T. Self care and medication adherence among type 2 diabetics in Puducherry, Southern India: a hospital based study. J Clin Diagn Res. 2014;8(4):Uc01–03. doi:10.7860/JCDR/2014/7732.4256.
   PubMedGoogle Scholar
• Kumar N, Unnikrishnan B, Thapar R, et al. Factors associated with adherence to antihypertensive treatment among patients attending a tertiary care hospital in Mangalore, South India. Int J Cur Res Rev. 2014;6(10):77–85.
   Google Scholar
• Do AT, Pillai MR, Balakrishnan V, et al. Effectiveness of glaucoma counseling on rates of follow-up and glaucoma knowledge in a South Indian population. Am J Ophthalmol. 2016;163:180–189.e184. doi:10.1016/j.ajo.2015.12.009.
   PubMed Web of Science ®Google Scholar
• Gupta V, Chandra A, Yogi R, Sihota R, Singh D. Prevalence and causes of patient dropout after glaucoma surgery. Ophthalmic Epidemiol. 2013;20(1):40–44. doi:10.3109/09286586.2012.741278.
   PubMed Web of Science ®Google Scholar
• Lee BW, Sathyan P, John RK, Singh K, Robin AL. Predictors of and barriers associated with poor follow-up in patients with glaucoma in South India. Arch Ophthalmol. 2008;126(10):1448–1454. doi:10.1001/archopht.126.10.1448.
   PubMedGoogle Scholar
• Robin AL, Nirmalan PK, Krishnadas R, et al. The utilization of eye care services by persons with glaucoma in rural south India. Trans Am Ophthalmol Soc. 2004;102:47–54. discussion 54-45.
   PubMedGoogle Scholar
• Nirmalan PK, Katz J, Robin AL, et al. Utilisation of eye care services in rural south India: the Aravind comprehensive eye survey. Br J Ophthalmol. 2004;88(10):1237–1241. doi:10.1136/bjo.2004.042606.
   PubMed Web of Science ®Google Scholar
• Ramakrishnan R, Nirmalan PK, Krishnadas R, et al. Glaucoma in a rural population of southern India: the Aravind comprehensive eye survey. Ophthalmology. 2003;110(8):1484–1490. doi:10.1016/S0161-6420(03)00564-5.
   PubMed Web of Science ®Google Scholar
• Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10(5):348–354. doi:10.1111/j.1751-7176.2008.-07572.x.
   PubMed Web of Science ®Google Scholar
• Venkatachalam J, Abrahm SB, Singh Z, Stalin P, Sathya GR. Determinants of patient’s adherence to hypertension medications in a rural population of Kancheepuram District in Tamil Nadu, South India. Indian J Community Med. 2015;40(1):33–37. doi:10.4103/0970-0218.149267.
   PubMedGoogle Scholar
• Killeen OJ, MacKenzie C, Heisler M, Resnicow K, Lee PP, Newman-Casey PA. User-centered design of the eyeGuide: a tailored glaucoma behavior change program. J Glaucoma. 2016;25(10):815–821. doi:10.1097/IJG.0000000000000431.
   PubMed Web of Science ®Google Scholar
• Newman-Casey PA, Robin AL, Blachley T, et al. The most common barriers to glaucoma medication adherence: a cross-sectional survey. Ophthalmology. 2015;122(7):1308–1316. doi:10.1016/j.ophtha.2015.03.026.
   PubMed Web of Science ®Google Scholar
• Unni EJ, Farris KB. Unintentional non-adherence and belief in medicines in older adults. Patient Educ Couns. 2011;83(2):265–268. doi:10.1016/j.pec.2010.05.006.
   PubMed Web of Science ®Google Scholar
• Brhlikova P, Harper I, Jeffery R, Rawal N, Subedi M, Santhosh M. Trust and the regulation of pharmaceuticals: South Asia in a globalised world. Global Health. 2011;7:10. doi:10.1186/1744-8603-7-10.
   PubMed Web of Science ®Google Scholar
• Control CfD, Prevention. The Social-ecological Model: A Framework for Prevention. Atlanta, GA: CDC; 2015.
   Google Scholar
• Ryan RM, Deci EL. Self-determination theory and the facilitation of intrinsic motivation, social development, and well-being. Am Psychol. 2000;55(1):68–78. doi:10.1037/0003-066X.55.1.68.
   PubMed Web of Science ®Google Scholar
• Ng JY, Ntoumanis N, Thogersen-Ntoumani C, et al. Self-Determination theory applied to health contexts: a meta-analysis. Perspect Psychol Sci. 2012;7(4):325–340. doi:10.1177/1745691612447309.
   PubMedGoogle Scholar
• Tripathi R, Cervone D, Savani K. Are the motivational effects of autonomy-supportive conditions Universal? Contrasting results among Indians and Americans. Pers Soc Psychol Bull. 2018;44(9):1287–1301. doi:10.1177/0146167218764663.
   PubMed Web of Science ®Google Scholar
• Seetharam S, Zanotti R. Patients’ perceptions on healthcare decision making in rural India: a qualitative study and ethical analysis. J Clin Ethics. 2009;20:150–157.
   PubMedGoogle Scholar